Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Aug 15, 2025, 3:59 PM
1.23
-0.40%
After-hours: Aug 15, 2025, 07:58 PM EDT
Lexicon Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 21.36M | 62.89M | 66.66M | 34.55M | 35.62M | 96.49M | 22.46M | 21.12M | 102.27M | 26M | 46.34M | 18.83M | 21.45M | 59.52M | 64.06M | 92.12M | 118.5M | 97.65M |
Short-Term Investments | 117.64M | 131.95M | 171.3M | 223.82M | 274.35M | 259.1M | 147.56M | 197.31M | 154.47M | 79.94M | 92.01M | 117.37M | 40.52M | 26.98M | 22.68M | 28.8M | 28.61M | 43.71M |
Long-Term Investments | 29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 368K | 368K | 368K | 828K | 828K | 828K | 828K | 6.43M | -53M | 6.42M | 6.82M | 7.15M | 1.85M | 2.06M | 2.27M | 2.47M | 2.67M | 3M |
Receivables | 2.18M | 47.45M | 3.47M | 2.9M | 2.62M | 1.53M | 1.01M | 318K | 685K | 261K | 28K | 39K | 34K | 37K | 14K | 23K | 159K | 101K |
Inventory | 168K | 201K | 231K | 636K | 585K | 514K | 381K | 336K | 172K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.73M | 3.32M | 4.53M | 6.71M | 7.67M | 7.01M | 5.13M | 4.29M | 6.12M | 3.35M | 2.48M | 2.82M | n/a | 1.89M | 2.16M | 3.06M | 4.6M | 3.95M |
Total Current Assets | 145.08M | 245.81M | 246.19M | 268.61M | 320.84M | 364.65M | 176.55M | 223.37M | 263.72M | 109.55M | 140.87M | 139.06M | 64.9M | 88.43M | 88.92M | 124M | 123.26M | 145.42M |
Property-Plant & Equipment | 6.59M | 6.95M | 7.32M | 7.15M | 7.14M | 7.2M | 7.51M | 2.13M | 8.46M | 2.21M | 2.07M | 932K | 1.03M | 1.14M | 1.18M | 1.31M | 1.2M | 296K |
Goodwill & Intangibles | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
Total Long-Term Assets | 80.5M | 51.87M | 52.23M | 52.52M | 52.51M | 52.57M | 52.88M | 53.11M | 53M | 53.17M | 53.43M | 52.62M | 47.43M | 47.75M | 47.99M | 48.33M | 48.41M | 47.84M |
Total Assets | 225.58M | 297.67M | 298.42M | 321.12M | 373.36M | 417.22M | 229.43M | 276.48M | 316.72M | 162.72M | 194.3M | 191.69M | 112.33M | 136.18M | 136.91M | 172.33M | 171.67M | 193.26M |
Account Payables | 5.9M | 10.69M | 14.8M | 14.2M | 12.22M | 8.07M | 14.39M | 12.04M | 10.5M | 10.31M | 10.39M | 9.43M | 7.35M | 9.32M | 9.15M | 8.35M | 8.54M | 4.93M |
Deferred Revenue | 17.46M | 45M | n/a | n/a | n/a | n/a | n/a | -1.29M | -1.29M | n/a | n/a | n/a | n/a | n/a | -1.09M | n/a | 10.41M | 20.06M |
Short-Term Debt | 909K | 42.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.69M | 11.68M | 11.66M |
Other Current Liabilities | 6.28M | 3.77M | 14.56M | 9.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 34.84M | 110.69M | 45.25M | 36.05M | 27.88M | 23.4M | 31.55M | 32.26M | 26.11M | 20.37M | 23.17M | 18.45M | 16.86M | 18.91M | 22.12M | 34.25M | 32.81M | 38.99M |
Long-Term Debt | 56.11M | 58.64M | 100.3M | 99.89M | 99.5M | 99.87M | 99.51M | 99.27M | 98.77M | 48.84M | 48.58M | 23.78M | 23.63M | 23.48M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 765K | 5.3M | 2.32M | 1.99M | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.62M | 1.72M |
Total Long-Term Liabilities | 61.31M | 63.95M | 107.22M | 106.56M | 105.5M | 104.95M | 104.77M | 104.71M | 104.25M | 54.3M | 54M | 29.22M | 24.63M | 24.57M | 1.19M | 1.48M | 1.62M | 1.72M |
Total Liabilities | 96.14M | 174.64M | 152.47M | 142.61M | 133.38M | 128.35M | 136.32M | 136.97M | 130.36M | 74.67M | 77.17M | 47.67M | 41.49M | 43.48M | 23.31M | 35.73M | 34.44M | 40.71M |
Total Debt | 61.45M | 101.74M | 106.07M | 105.87M | 105.68M | 106.24M | 106.06M | 106M | 105.55M | 54.3M | 55.29M | 30.63M | 25.42M | 25.52M | 2.28M | 14.2M | 12.7M | 12.69M |
Common Stock | 366K | 366K | 363K | 363K | 363K | 248K | 245K | 245K | 245K | 190K | 189K | 189K | 150K | 150K | 150K | 150K | 146K | 145K |
Retained Earnings | -1.99B | -1.99B | -1.97B | -1.93B | -1.87B | -1.82B | -1.77B | -1.72B | -1.67B | -1.62B | -1.59B | -1.56B | -1.54B | -1.51B | -1.49B | -1.46B | -1.44B | -1.42B |
Comprehensive Income | -14K | 25K | 119K | 349K | -193K | -50K | 31K | -113K | -100K | -163K | -428K | -491K | -150K | -37K | -10K | -6K | -5K | 5K |
Shareholders Equity | 129.44M | 123.03M | 145.95M | 178.51M | 239.98M | 288.87M | 93.11M | -1.72B | -1.67B | -1.62B | -1.59B | 144.02M | -1.54B | 92.7M | -1.49B | 136.6M | 137.23M | 152.55M |
Total Investments | 146.64M | 131.95M | 171.3M | 223.82M | 274.35M | 259.1M | 147.56M | 197.31M | 154.47M | 79.94M | 92.01M | 117.37M | 40.52M | 26.98M | 22.68M | 28.8M | 28.61M | 43.71M |